Cerecin
Cerecin, formerly Accera, is a company that looks to develop therapeutic drugs for neurodegenerative diseases.
7
Funding Rounds
$189.5m
Money raised
Funding
Funding series
Funding Series Analysis
The company Cerecin has raised a total of $189.5m in funding over 7 rounds.
Key Insights:
- Cerecin Funding Round, August 2022: $40m
- Cerecin Series A round, October 2021: $40m
- Cerecin Funding round, October 2018: $50m
- Accera Series D round: $11m
- Accera Series C round: $35m
- Accera Series B round: $7.5m
- Accera Series A round: $6m
Cerecin Funding Round, August 2022
$40m
Cerecin Series A round, October 2021
$40m
Cerecin Funding round, October 2018
$50m
Accera Series D round
$11m
Accera Series C round
$35m
Accera Series B round
$7.5m
Accera Series A round
$6m
Industries
Cerecin is active in the following industries: